Provided by Tiger Trade Technology Pte. Ltd.

Stoke Therapeutics, Inc.

38.35
+0.03500.09%
Volume:782.91K
Turnover:30.72M
Market Cap:2.19B
PE:56.00
High:40.22
Open:39.06
Low:38.03
Close:38.31
52wk High:40.22
52wk Low:5.35
Shares:57.12M
Float Shares:38.09M
Volume Ratio:1.09
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6847
EPS(LYR):-1.6475
ROE:15.02%
ROA:5.20%
PB:7.11
PE(LYR):-23.27

Loading ...

Jefferies Sticks to Their Buy Rating for Stoke Therapeutics (STOK)

TIPRANKS
·
Nov 24, 2025

BRIEF-Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Nov 19, 2025

Director Adrian R. Krainer Reports Sale of Stoke Therapeutics Inc. Common Shares

Reuters
·
Nov 19, 2025

Stoke Therapeutics Grants Stock Options to New Senior VP and Employees

Reuters
·
Nov 19, 2025

Could Endpoint Choices in the EMPEROR Trial Reveal a Strategic Shift for Stoke Therapeutics (STOK)?

Simply Wall St.
·
Nov 18, 2025

Biogen and Stoke Therapeutics Publish Two-Year Study Highlighting Severity of Dravet Syndrome

Reuters
·
Nov 17, 2025

Stoke Therapeutics Inc : Wedbush Raises Target Price to $32 From $22

THOMSON REUTERS
·
Nov 05, 2025

Stock Track | Stoke Therapeutics Plunges 6.08% After Hours on Mixed Q3 Results and Wider-than-Expected Loss

Stock Track
·
Nov 05, 2025

Stoke Therapeutics Q3 revenue beats estimates on Acadia, Biogen agreements

Reuters
·
Nov 05, 2025

Stoke Therapeutics reports third quarter sales, general and administrative expenses of $45.9 million

Reuters
·
Nov 05, 2025

Stoke Therapeutics Inc - Has $328.6 Mln in Cash as of Sept 30, Anticipated to Fund Operations to Mid-2028

THOMSON REUTERS
·
Nov 05, 2025

Stoke Therapeutics Down Over 16%, on Pace for Largest Percent Decrease Since February 2024 -- Data Talk

Dow Jones
·
Nov 04, 2025

Stoke Therapeutics Inc : JP Morgan Raises Target Price to $25 From $15

THOMSON REUTERS
·
Nov 03, 2025

Stoke Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview

Reuters
·
Nov 01, 2025

Press Release: Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates

Dow Jones
·
Oct 31, 2025

Stoke Therapeutics Unveils Two-Year ADOA Study Data at AAO Meeting

Reuters
·
Oct 20, 2025

Stoke Therapeutics Grants Stock Options to New Employees Under 2023 Inducement Plan

Reuters
·
Oct 17, 2025

BTIG Sticks to Their Buy Rating for Stoke Therapeutics (STOK)

TIPRANKS
·
Oct 14, 2025

Stoke Therapeutics Director Edward M. Kaye, MD Reports Disposal of Common Shares

Reuters
·
Oct 11, 2025

Stoke Therapeutics Inc : Needham Raises Target Price to $35 From $22

THOMSON REUTERS
·
Oct 10, 2025